We have preliminary data showing that in ovarian cancer patient xenografts made resistant in vivo to cisplatin, a higher level of ERCC1/XPF complex detected by PLA was found compared to platinum-sensitive xenografts [97]. Here, ERCC4 is linked to ovarian carcinoma.